Review
Published on 03 Apr 2025
Engineered nanoparticles for the treatment of Alzheimer’s disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1510798
- 770 views
Type at least 3 characters
2,415 articles
Review
Published on 03 Apr 2025
Natural products protect against spinal cord injury by inhibiting ferroptosis: a literature review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1557133
- 1,077 views
Original Research
Accepted on 02 Apr 2025
Title Functional Ultrasound Imaging and Prewhitening Analysis Reveal MK-801-Induced Disruption of Brain Network Connectivity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1562102
Review
Published on 02 Apr 2025
Global research frontiers and thematic trends in opioid-free anesthesia over the past 20Â years: a bibliometric analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1562765
- 831 views
Original Research
Published on 02 Apr 2025
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559447
- 1,458 views
Original Research
Published on 01 Apr 2025
A novel antidepressant mechanism of baicalin: enhancing KIF5A-mediated axoplasmic transport and vesicular trafficking in glutamatergic neurons
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1577676
- 710 views
Original Research
Published on 01 Apr 2025
Increase of Brivaracetam serum concentration with introduction of Cenobamate
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1571376
- 791 views
Original Research
Published on 01 Apr 2025
A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561020
- 937 views
Original Research
Accepted on 31 Mar 2025
Preventive Beneficial Effects of Cannabidiol in a Reserpine-Induced Progressive Model of Parkinsonism
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1539783
- 199 views
Correction
Published on 31 Mar 2025
Corrigendum: Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592653
- 450 views
Original Research
Published on 31 Mar 2025
BAM8-22 targets spinal MrgC receptors to modulate UPRmt activity in the mechanism of bone cancer pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1575733
- 712 views
Systematic Review
Published on 28 Mar 2025
Effect and safety of perioperative ketamine/esketamine administration on postoperative pain and depression after breast cancer surgery: a systematic review and meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532524
- 995 views
Systematic Review
Published on 27 Mar 2025
Effects of natural extracts in cognitive function of healthy adults: a systematic review and network meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1573034
- 1,024 views
Review
Published on 26 Mar 2025
Exosomes: an innovative therapeutic target for cerebral ischemia-reperfusion injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1552500
- 1,128 views
Review
Published on 26 Mar 2025
The role and therapeutic potential of mitophagy in major depressive disorder
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1564276
- 641 views
Original Research
Published on 26 Mar 2025
The astrocytic sigma-1 receptor constitutes in the fast antidepressant action of hypidone hydrochloride (YL-0919) in rodents
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1564851
- 639 views